Last Modified: 8/8/2024
Location: FL, PR, USVI
Business: Part A, Part B
The spine is the most common source of chronic pain. Chronic axial spinal pain is one of the major causes of disability. The facet joints can cause axial spinal pain and referred pain in the extremities. The pathology of the pain source is due to facet joints being richly innervated by the nerve fibers from the medial branch of the dorsal ramus of spinal nerves.
Facet joint interventions may be used in pain management for chronic cervical/thoracic and lumbar/sacral pain arising from the paravertebral facet joints. Imaging guidance (fluoroscopy or CT per code descriptor) is used to assure accurate placement of the needle for the injection. Paravertebral facet joint denervation is a therapeutic intervention used to provide both long-term pain relief and reduce the likelihood of recurrence of chronic cervical/thoracic or lumbar/sacral pain confirmed as originating in the facet joint’s medial branch nerve.
Facet joint interventions performed in a hospital outpatient department (HOPD) will require prior authorization (PA) for dates of service on or after July 1, 2023, for the CPT codes listed in Table 1.
Table 1. Facet Joint Intervention CPT codes
|
|
64490 |
Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), cervical or thoracic; single level |
64491 |
Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), cervical or thoracic; second level |
64493 |
Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level |
64494 |
Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level |
64633 |
Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); cervical or thoracic, single facet joint |
64634 |
Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); cervical or thoracic, each additional facet joint |
64635 |
Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, single facet joint |
64636 |
Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, each additional facet joint |
Note: The following CPT codes were removed on August 16, 2024, and no longer require prior authorization:
• 64492 (Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), cervical or thoracic; third and any additional level(s))
• 64495 (Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; third and any additional level(s))
Three (3) or four (4) level procedures are not medically necessary and therefore are non-covered.
Providers should include the following documentation with their Facet Joint Interventions PA request:
• Clear indication of what is being requested
• History and physical
• Physician orders and progress notes
• Diagnostic test results
• Procedure records
• Pain history to include location, severity, and duration
• Evidence of failed conservative management
• Disability scale rating or an H/P that clearly describes functional disability for each new episode of pain
• Patient response to prior facet joint interventions, if applicable
• Medical history records
• Signature attestation form, if applicable
Diagnostic facet joint procedures are used to diagnose facet syndrome with the injection of a local anesthetic, with or without a steroid medication, either into the facet joint (intra-articular) or outside the joint space around the nerve supply to the joint (the medial branch nerve) known as medial branch block (MBB). Intraarticular (IA) facet blocks as a diagnostic test may only be reasonable and necessary if medial branch blocks (MBB) cannot be performed. Restrictions must be clearly documented in the medical record (anatomic restrictions or an indication to proceed with therapeutic IA injections). Diagnostic procedures should be performed with the intent that if successful, radiofrequency ablation procedure would be the primary treatment goal at the diagnosed level.
Requirements for the FIRST diagnostic procedure:
• Moderate to severe chronic neck or low back pain, predominantly axial, that causes functional deficit measured on pain or disability scale
• Pain present for minimum of three months with documented failure to respond to noninvasive conservative management (as tolerated)
• Absence of untreated radiculopathy or neurogenic claudication (except for radiculopathy caused by facet joint synovial cyst); and
• There is no non-facet pathology per clinical assessment or radiology studies that could explain the source of the patient’s pain, including but not limited to fracture, tumor, infection, or significant deformity.
Requirements for the SECOND confirmatory procedure:
• Meets requirements for the first diagnostic and
• After the first diagnostic procedure, there is at least 80% relief of primary pain.
• The second diagnostic procedure may only be performed a minimum of two weeks after the initial diagnostic procedure. Exception to the two-weeks duration may be considered on an individual basis and must be clearly documented in the medical record.
Frequency limitation: For each covered spinal region no more than four diagnostic joint sessions will be reimbursed per rolling 12 months.
Therapeutic facet joint procedures are considered medically reasonable and necessary for patients who meet all the following criteria:
• The patient has had two medically reasonable and necessary diagnostic facet joint procedures with each one providing a minimum of 80% consistent relief of primary (index) pain (with the duration of relief being consistent with the agent used); and
• Subsequent therapeutic facet joint procedures at the same anatomic site result in at least 50% consistent pain relief for at least three months from the prior therapeutic procedure or at least 50% consistent improvement in the ability to perform previously painful movements and ADLs as compared to baseline measurement using the same scale; and
• Documentation of why the patient is not a candidate for radiofrequency ablation (such as established spinal pseudarthrosis, implanted electrical device) is clearly documented in the medical record.
Frequency limitation: For each covered spinal region no more than four therapeutic facet joint injection (IA) sessions will be reimbursed per rolling 12 months.
RFA uses radio waves to stop medial branch nerves from transmitting pain signals from the injured facet joint to the brain; involved heating a part of the pain transmitting nerve with a radiofrequency needle to create a heat lesion (resulting lesion prevents the nerve from sending pain signals to the brain).
A facet joint denervation is the preferred method of treatment for facet joint syndrome. If a denervation is not an option, there needs to be supporting documentation providing reasons why this intervention cannot be performed.
The thermal radiofrequency destruction of cervical, thoracic, or lumbar paravertebral facet joint (medial branch) nerves are considered medically reasonable and necessary for patients who meet all the following criteria:
a. Initial thermal RFA:
i. After the patient has had at least two medically reasonable and necessary diagnostic MBBs, with each one providing a consistent minimum of 80% sustained relief of primary (index) pain (with the duration of relief being consistent with the agent used)
b. Repeat thermal facet joint RFA:
i. After the patient has had at least two medically reasonable and necessary diagnostic MBBs, with each one providing a consistent minimum of 80% sustained relief of primary (index) pain (with the duration of relief being consistent with the agent used) and
ii. RFA is at the same anatomic site is considered medically reasonable and necessary provided the patient had a minimum of consistent 50% improvement in pain for at least six months and at least 50% consistent improvement in the ability to perform previously painful movements and ADLs as compared to baseline measurement using the same scale.
The CPT codes for radiofrequency ablation (RFA)/denervation prior authorization include:
Cervical or thoracic joints:
64633 (single level)
64634 (additional levels – must be reported with 64633)
Lumbar or sacral joints:
64635 (single level)
64636 (additional levels – must be reported with 64635)
Frequency limitation: For each spinal area there can be no more than two RFA sessions over a 12-month rolling period.
The A/B Medicare Administrative Contractor Prior Authorization Collaboration Workgroup developed this document. This joint effort ensures consistent communication and education throughout the nation on a variety of topics and assists the provider and physician community with information necessary to submit claims appropriately and receive proper payment in a timely manner at the end of document.
First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.